| Drug Name |
Palifermin |
| Drug ID |
BADD_D01655 |
| Description |
Palifermin is a recombinant human keratinocyte growth factor (KGF). It is 140 residues long, and is produced using E. coli.
Palifermin was granted FDA approval on 15 December 2004.[L17933] |
| Indications and Usage |
For treatment of oral mucositis associated with chemotherapy and radiation therapy. |
| Marketing Status |
Prescription |
| ATC Code |
V03AF08 |
| DrugBank ID |
DB00039
|
| KEGG ID |
D05338
|
| MeSH ID |
D051523
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D0O7GU
|
| NDC Product Code |
66658-112 |
| Synonyms |
Fibroblast Growth Factor 7 | Keratinocyte Growth Factor | Palifermin |
